Affimed Highlights the Potential of its Innate Cell Engager AFM24 as EGFR-targeting Therapy for Solid Tumors as Monotherapy and in Combination with Adoptive NK Cell Transfer at AACR Virtual Annual Meeting I
April 12, 2021
April 12, 2021
April 9, 2021
April 8, 2021
March 31, 2021
March 10, 2021
March 10, 2021
February 3, 2021
January 15, 2021
January 13, 2021
January 12, 2021